Two Items Key To Decrease Symptoms And Prolong Survival For Leptomeningeal Carcinomatosis Patients
Now research published in the International Association for the Study of Lung Cancer's Journal of Thoracic Oncology (JTO) shows the effectiveness of intraventricular chemotherapy (chemotherapy injected directly into the ventricles of the brain) in terms of symptom response rate and overall survival in patients with LMC from non-small cell lung cancer (NSCLC).
Researchers from the National Cancer Center in Goyang, Korea did a retrospective analysis on 105 patients with NSCLC who had undergone intraventricular chemotherapy. They conclude that intraventricular chemotherapy for patients with LMC from NSCLC could palliate associated symptoms and prolong patients' survival.
"Among the 54 patients with increased ICP at the entry of the treatment," the study says, "20 patients achieved normal ICP (< 15 cm H2O) after the intraventricular chemotherapy, excluding three patients who underwent a ventriculo-peritoneal shunt. However, 15 of 51 patients with normal ICP at the start of treatment showed increased ICP during the course of the therapy and remained uncontrolled. Thus, the total increased ICP control rate of intraventricular therapy was 20 of 69 (29 percent)."
As a result, the researchers conclude that, "Careful selection of patients for intraventricular chemotherapy is recommended, with aggressive ICP control, and concurrent systemic chemotherapy."
The lead author of this work is Dr. Ho-Shin Gwak. Co-authors include IASLC members Dr. Sang Hoon Shin, Dr. Ji-Youn Han, Dr. Heung Tae Kim and Dr. Jin Soo Lee.
International Association for the Study of Lung Cancer
Source: EurekAlert!, the online, global news service operated by AAAS, the science society
Please use one of the following formats to cite this article in your essay, paper or report:
International Association for the Study of Lung Ca. "Two Items Key To Decrease Symptoms And Prolong Survival For Leptomeningeal Carcinomatosis Patients." Medical News Today. MediLexicon, Intl., 24 Apr. 2013. Web.
24 May. 2017. <http://www.medicalnewstoday.com/releases/259522.php>
International Association for the Study of Lung Ca. (2013, April 24). "Two Items Key To Decrease Symptoms And Prolong Survival For Leptomeningeal Carcinomatosis Patients." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.